|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C67.1 |
Malignant neoplasm of dome of bladder
|
C671 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 59.98%
|
24.17%
|
7.56%
|
3.38%
|
1.67%
|
1.07%
|
0.79%
|
0.31%
|
0.30%
|
0.28%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C67.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
2,448
|
3,757
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,249
|
53,940
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,198
|
9,482
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,176
|
2,176
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,139
|
2,153
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,899
|
1,899
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,749
|
1,756
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,687
|
1,977
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,573
|
6,198
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,569
|
10,600
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,378
|
2,069
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,219
|
3,730
|
|
J7120
|
RINGERS LACTATE INFUSION |
1,075
|
1,380
|
|
52235
|
CYSTOSCOPY AND TREATMENT |
1,017
|
1,017
|
|
80048
|
METABOLIC PANEL TOTAL CA |
851
|
851
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
849
|
2,756
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
845
|
70,430
|
|
52234
|
CYSTOSCOPY AND TREATMENT |
817
|
817
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
810
|
1,648
|
|
51720
|
TREATMENT OF BLADDER LESION |
792
|
792
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C67.1 related to the following DRG Codes:
656-658
686-688
|
